Evidence map›Paper›PMID 28785483›Full record

ReviewJournal of ophthalmology2017

Peripheral Ulcerative Keratitis Associated with Autoimmune Disease: Pathogenesis and Treatment.

Yan Cao, Wensong Zhang, Jie Wu, Hong Zhang, Hongyan Zhou

Open access · goldAbstract readReview
In one paragraph

Review in Journal of ophthalmology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 30 papers.

0numbers the graph read from it
0cells of the map it votes in
30citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

30 citing papers in PubMed, 88 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Article
  13. Review
  14. Case reports in ophthalmological medicine · 2022
    Article
  15. MALT Lymphoma Presenting with Peripheral Ulcerative Keratitis.International medical case reports journal · 2022
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Systemic diseases and the cornea.Experimental eye research · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 1 country.

Yan CaoDepartment of Ophthalmology, China-Japan Union Hospital of Jilin University, Changchun City, China.
Wensong ZhangDepartment of Ophthalmology, The Second Hospital of Jilin University, Changchun City, China.
Jie WuDepartment of Ophthalmology, China-Japan Union Hospital of Jilin University, Changchun City, China.
Hong ZhangDepartment of Ophthalmology, China-Japan Union Hospital of Jilin University, Changchun City, China.
Hongyan ZhouDepartment of Ophthalmology, China-Japan Union Hospital of Jilin University, Changchun City, China.ORCID 0000-0002-9878-2519
Jilin University · CNSecond Affiliated Hospital of Jilin University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Peripheral ulcerative keratitis (PUK) is type of crescent-shaped inflammatory damage that occurs in the limbal region of the cornea. PUK is always combined with an epithelial defect and the destruction of the peripheral corneal stroma. PUK may have a connection to systemic conditions, such as long-standing rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), Wegener granulomatosis (WG), relapsing polychondritis, classic polyarteritis nodosa and its variants, microscopic polyangiitis, and Churg-Strauss syndrome. However, the most common connection is with RA, which is also the focus of this review. The pathogenesis of PUK is still unclear. It is thought that circulating immune complexes and cytokines exert an important influence on the progression of this syndrome. Treatment is applied to inhibit certain aspects of PUK pathogenesis.

Identifiers

PMID28785483
PMCPMC5530438
OpenAlexW2734867929

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.